Ovarian cancer screening aims to detect the disease at an early stage when treatment is more likely to be successful, but currently, there is no universally accepted screening method due to the lack of specificity and sensitivity in existing tests. Research continues to focus on developing more accurate screening techniques, including blood tests for biomarkers and advanced imaging technologies, to improve early detection rates and survival outcomes.